Details for Patent: 11,925,661

Which drugs does patent 11,925,661 protect, and when does it expire?

Patent 11,925,661 protects POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE and is included in one NDA.

Summary for Patent: 11,925,661

Title:	Ready-to-use potassium phosphates in sodium chloride solutions
Abstract:	Ready-to-use (RTU) potassium phosphates solutions for phosphorus replacement therapy are presented that include potassium phosphate and sodium chloride at a fixed volume with 1.5 to 15 mmol/100 mL phosphorus, no more than 22 mEq/100 mL potassium and less than 50 mcg/L aluminum.
Inventor(s):	Brijeshkumar B. Pandya, Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Anand Shukla, Jwalant Shukla
Assignee:	Nivagen Pharmaceuticals Inc
Application Number:	US18/460,941
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,925,661
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 11,925,661

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fresenius Kabi Usa	POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE	potassium phosphate, dibasic; potassium phosphate, monobasic	SOLUTION;INTRAVENOUS	212832-004	May 9, 2025		RX	Yes	Yes			Y			METHOD TO PROVIDE PHOSPHORUS REPLACEMENT BY ADMINISTERING WITHOUT PRIOR DILUTION AN ISOTONIC, STERILE, AND READY-TO-USE SOLUTION COMPRISING ABOUT 15 MMOL PHOSPHORUS AND ABOUT 22 MEQ POTASSIUM FROM A FLEXIBLE CONTAINER
Fresenius Kabi Usa	POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE	potassium phosphate, dibasic; potassium phosphate, monobasic	SOLUTION;INTRAVENOUS	212832-005	May 9, 2025		RX	Yes	Yes			Y			METHOD TO PROVIDE PHOSPHORUS REPLACEMENT BY ADMINISTERING WITHOUT PRIOR DILUTION AN ISOTONIC, STERILE, AND READY-TO-USE SOLUTION COMPRISING ABOUT 15 MMOL PHOSPHORUS AND ABOUT 22 MEQ POTASSIUM FROM A FLEXIBLE CONTAINER